Union Korea Pharm Co., Ltd.

₩8,175As of Sun 8 Nov 2026, 12:00 UTC
KOSDAQ:080720Healthcare
Country South Korea
PE (Fwd) •••
TSR 8Y CAGR (20.41%)
Div yield —
ROE (137.86%)
Pharmaceutical Preparations
Beta (5Y) 0.01
PE TTM —
TSR TTM —
Mkt cap ₩19.70B
ROIC (558.73%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
₩10,627
30.00%
(2.77%)
Hold 10|5|6|12|6
4Q25
1Q26
2Q26
3Q26
Earnings per share₩
92.62
89.83
100.54
102.52
15.39%
9.74%
15.41%
8.52%
Revenue₩B
1.823
1.776
1.843
1.876
19.86%
10.62%
10.44%
8.82%
Peers (US$14.52M)
Cap (US$)
PE
14.50M
11.31x
14.32M
10.49x
Capital
TTM
5Y
10Y
Leveragex
1.195
0.058
0.060
EBIT/Intx
0.649
0.270
0.287
Own earn%
(7.94)
(2.69)
2.51
Sh yield%
36.86
11.55
14.58
Owners
Insiders/Inst%
4.88
24.00
Short interest%
0.94
SBC / revenue%
1.77
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
14
Op margin range%
21–26
$1 testx
−0.1
Incr. ROIC%
9